1Nishimori H, Shiratsuchi T, Urano T, et al. A novel brain - specific p5 3 - target gene, BAIl, containing thrombospondin type 1 repeats inhibits experimental anglogenesis. Oneogene, 1997,15 ( 18 ) : 2145 -2150.
2Yoon KC, Ahn KY, Lee JH, et al. Lipid - mediated delivery of brain -specific angiogenesis inhibitor 1 gene reduces corneal neovasct- darization in an in vivo rabbit model. Gene Ther,2005,12 (7) :617 - 624.
3Duda DG, Sunamura M, Lezomehi L, et al. Overexpression of the p53 - - inducible brain - , specific angiogenesis inhibitor 1 sup- presses efficiently tumour angingenesis. Bri J of Cancer, 2002,86 ( 3 ) :490 - 496.
6Guo N, Krutzsch HC,Inman JK, et al. Thrombospondin 1 and type I repeat pepfides of thrombospondin 1 specifically in - duce apop- tosis of endothehM cells. Cancer Res, 1997,57(9) :1735. 1742.
7Tohma SS, Volpert OV, Good DJ, et al. Peptides derived from two separate domains of the matrix protein thrombospondin - 1 have an- ti - angiogenic activity. J Cell Bid, 1993,122 ( 2 ) :497 - 511.
8Kaur B, Brat DJ, Devi NS, et al. Vaseulestatin, a proteolytic frag- ment of brain angiogenesis inhibitor 1, is antigiogenic and antitu- morigenic factor. Oncogene ,2005,24 ( 22 ) :3632 - 3642.
9Koh JT, Kook H, Kee H J, et al. Extracellular fragment of brain - specific angiagenesis inhibitor 1 suppresses endothelial cell prolif- eration by blocking arG5 integrin. Experimental Cell Research, 2004,294(1) :172 -1 84.
10Dawson DW, Pearee SF, Zhong R, et al. CD36 mediates the in vitro inhibitory effects of thrombospondin - 1 on endothelial cells. J Cell Bio1,1997,1 38(3) :707 -717.
